Geron CORP Form 4 insider transactions

Robert J. Spiegel, a Director at Geron Corp, received 6,103 shares of common stock as compensation for his board services.

Robert J. Spiegel, a Director at Geron Corp, has acquired 220,000 stock options with an exercise price of $1.26, vesting on May 20, 2026.

Geron Corporation reports that Director Elizabeth G. O'Farrell was granted a stock option for 220,000 shares.

Geron Corporation director Susan Molineaux has acquired 220,000 stock options, with vesting contingent on continuous service and company meeting dates.

John F. McDonald, a Director at Geron Corp, has acquired 220,000 stock options with an exercise price of $1.26, exercisable on May 20, 2026.

Geron Corporation Director Dawn Carter has been granted a stock option for 220,000 shares of common stock.

Geron Corporation's EVP and Chief Legal Officer, Timothy Williams, acquired 2,500,000 stock options with an exercise price of $1.73.

Geron Corporation's Director, Constantine Chinoporos, acquired 270,000 stock options with an exercise price of $1.57, vesting over three years.

Geron Corporation's Director, Patricia S. Andrews, was granted 270,000 stock options with an exercise price of $1.57, vesting over three years.

Geron Corporation's EVP of R&D and Chief Medical Officer, Joseph Eid, was granted 2.22 million stock options with an exercise price of $1.80 per share.

Geron Corporation's EVP and CFO, Michelle Robertson, reported the vesting of restricted stock units, a related tax-driven share sale, and the grant of new stock options.

Geron Corp. Director Robert J. Spiegel acquired 5,918 shares of common stock on December 31, 2025, as non-cash compensation.

Ahmed ElNawawi, Geron Corporation's EVP and Chief Commercial Officer, received a grant of 3 million stock options with an exercise price of $1.27, aligning executive incentives with long-term company performance.

Geron Corporation Director Robert J. Spiegel acquired 5,702 shares of common stock valued at $1.37 per share as part of his quarterly compensation.

Geron Corporation's President and CEO, Harout Semerjian, was granted 11 million stock options with an exercise price of $1.30, aligning executive incentives with long-term company performance.

Geron Corporation Director Robert J. Spiegel acquired 5,540 shares of common stock on June 30, 2025, as part of his non-cash compensation for board and committee fees.

Director Gaurav Aggarwal reports the acquisition of stock options in Geron Corp.

Dawn Carter Bir, Interim President and CEO of Geron Corporation, reports the acquisition of stock options.

Director V. Bryan Lawlis of Geron Corporation acquired 180,000 stock options on May 21, 2025, exercisable at $1.34, as reported in a Form 4 filing with the SEC.

Director John F. McDonald reports acquisition of 180,000 stock options in Geron Corporation.

Director Susan Molineaux reports acquisition of stock options in Geron Corporation.

Director Elizabeth G. O'Farrell acquired 180,000 stock options in Geron Corporation on May 21, 2025, according to a Form 4 filing.

Director Robert J. Spiegel reports acquisition of 180,000 stock options in Geron Corp.

Director V. Bryan Lawlis reports purchasing 13,300 shares of Geron Corp common stock at $1.178 per share on May 9, 2025.

Director Robert J. Spiegel increased his holdings in Geron Corp by acquiring 4,913 shares of common stock in lieu of cash compensation for board and committee fees.

Robert J. Spiegel, a director at Geron Corp, filed an amended Form 4 to correct a previous filing, accurately reporting the acquisition of 2,206 shares of common stock in lieu of cash compensation.

Robert J. Spiegel, a director at Geron Corporation, amended a previous Form 4 filing to accurately reflect the acquisition of 1,767 shares of common stock in lieu of cash compensation.

Robert J. Spiegel, a director at Geron Corp, amended a previous Form 4 filing to correctly report the acquisition of shares in lieu of cash compensation.

EVP and Chief Legal Officer of Geron Corporation, Scott Alan Samuels, reports purchasing 15,000 shares of common stock on the open market.

Geron Corporation's CEO, John A. Scarlett, recently purchased 12,500 shares of the company's common stock at a price of $1.765 per share.